| For: | Ventura Y, Carr BI, Kori I, Guerra V, Shibolet O. Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization. World J Gastroenterol 2018; 24(15): 1641-1649 [PMID: 29686471 DOI: 10.3748/wjg.v24.i15.1641] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v24/i15/1641.htm |
| Number | Citing Articles |
| 1 |
Brian I. Carr, Vito Guerra, Rossella Donghia, Seai Yilmaz. Relationships Between Indices of Tumor Aggressiveness in Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 2021; 52(4) doi: 10.1007/s12029-021-00720-z
|
| 2 |
Javeria Khalid, Mohammad Umar, Tofeeq Ur-Rehman, Mashhood Ali, Gul Majid Khan. Tumor aggression among hepatitis-C related hepatocellular carcinoma patients: an observational study regarding the impact of anti-HCV therapy. Infectious Agents and Cancer 2020; 15(1) doi: 10.1186/s13027-020-00300-z
|
| 3 |
Shuanggang Chen, Lujun Shen, Letao Lin, Han Qi, Boyang Chang, Qi Zeng, Linbin Lu, Jingjun Huang, Hongtong Tan, Fei Cao, Lin Xie, Tao Huang, Ying Wu, Chunyong Wen, Yujia Wang, Ruizhi Tang, Chen Li, Guanglei Zheng, Gulijiayina Nuerhashi, Weijun Fan. Development and validation of the NTAA prognostic model for BCLC stage B hepatocellular carcinoma undergoing transarterial chemoembolization: a retrospective multicenter cohort study. International Journal of Surgery 2025; 111(12) doi: 10.1097/JS9.0000000000003138
|
| 4 |
Ahmed A. Ghafar, Elsayed Ghoneem, Salah Rozaik, Ahmed Akef, Metwaly Mortada. Prognostic value of interleukin-10 and tumor necrosis factor-α polymorphisms in patients with hepatocellular carcinoma treated with transarterial chemoembolization. The Egyptian Journal of Internal Medicine 2019; 31(3) doi: 10.4103/ejim.ejim_110_18
|
| 5 |
Ahmed Saleh, Ahmed M. Saed, Mostafa Mansour. Association of IL-10 and TNF-α polymorphisms with risk and aggressiveness of hepatocellular carcinoma in patients with HCV-related cirrhosis. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00052-w
|
| 6 |
Zixin Huang, Manli Zhou, Sisi Feng, Xiaomin Xiao, Baiyun Zhong. Gamma-glutamyltransferase and the survival of hepatocellular carcinoma patients after transarterial chemoembolization: a meta‑analysis and systematic review. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04321-z
|
| 7 |
Hanyu Huang, Fan Yang, Pengcheng Liu, Kun Zhou, Wenzhi Chen. Constructing and validating a prognostic prediction nomogram model for hepatocellular carcinoma patients following high-intensity focused ultrasound treatment. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1789920
|
| 8 |
Satoyoshi Yamashita, Akira Kato, Toshitaka Akatsuka, Takashi Sawada, Tomohide Asai, Noriyuki Koyama, Kiwamu Okita. Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(13): 1463-1473 doi: 10.3748/wjg.v26.i13.1463
|
| 9 |
Han Li, Lu Guo, Ke Su, Changlun Li, Yi Jiang, Pan Wang, Jiali Chen, Zhenying Wu, Ke Xu, Tao Gu, Hao Zeng, Kun He, Hao Chi, Wenxi Zhao, Lei Han, Yunwei Han. Construction and Validation of TACE Therapeutic Efficacy by ALR Score and Nomogram: A Large, Multicenter Study. Journal of Hepatocellular Carcinoma 2023; doi: 10.2147/JHC.S414926
|
| 10 |
Ping Sun, Shihai Chen, Yanlong Li. The association between pretreatment serum alkaline phosphatase and prognosis in hepatocellular carcinoma. Medicine 2020; 99(11) doi: 10.1097/MD.0000000000019438
|